Question 1

What is the catalog number for EX 527 (Selisistat)?

Accepted Answer

The catalog number for EX 527 (Selisistat) is M14668.

Question 2

What sizes are available for EX 527 (Selisistat)?

Accepted Answer

EX 527 (Selisistat) is available in the following size(s): 1 g, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg.

Question 3

How many pack sizes does EX 527 (Selisistat) come in?

Accepted Answer

EX 527 (Selisistat) is available in 8 different pack sizes.

Question 4

Is EX 527 (Selisistat) in stock?

Accepted Answer

EX 527 (Selisistat) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is EX 527 (Selisistat) used for?

Accepted Answer

EX 527 is a potent and selective SIRT1 inhibitor with IC50 of 38 nM, exhibits >200-fold selectivity against SIRT2 and SIRT3.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 7

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 8

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

EX 527 (Selisistat)

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

CHAT Polyclonal Antibody

CHAT Polyclonal Antibody

CHAT Polyclonal Antibody

PI 3 Kinase p85 alpha (PIK3R1) Human Gene Knockout Kit (CRISPR)

Cytokeratin 8 (KRT8) (B22.1), CF740 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF640R conjugate, 0.1mg/mL